Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT02502162
NA
Low-Dose Naltrexone for the Treatment of Complex Regional Pain Syndrome
Sponsor: Stanford University
View on ClinicalTrials.gov
Summary
The investigators are testing treatment with low-dose naltrexone (LDN) for symptom relief of complex regional pain syndrome (CRPS). Study participants will be randomly assigned to receive either LDN or placebo for a period of several weeks. During this period participants will be asked to attend either in-person or virtual study visits and complete questionnaires.
Key Details
Gender
All
Age Range
18 Years - 70 Years
Study Type
INTERVENTIONAL
Enrollment
120
Start Date
2015-06
Completion Date
2027-07
Last Updated
2025-05-29
Healthy Volunteers
No
Conditions
Interventions
DRUG
LDN
DRUG
Placebo
Sugar pill
Locations (1)
Stanford University
Palo Alto, California, United States